Acucela Inc. Appoints Former Novartis Corporation Executive and Ophthalmic Expert, Al Reaves, Ph.D., to Management Team

SEATTLE--(BUSINESS WIRE)--Acucela Inc., a clinical-stage specialty pharmaceutical company focused on developing new treatments for blinding eye diseases, today announced that it has appointed Al Reaves, Ph.D. as the Company’s new Sr. Vice President, Therapeutic Development. As a member of Acucela’s growing management team, Dr. Reaves will be responsible for leading the direction of the Company’s clinical-stage programs.